289 related articles for article (PubMed ID: 21337123)
1. Mind-mapping for lung cancer: towards a personalized therapeutics approach.
Mollberg N; Surati M; Demchuk C; Fathi R; Salama AK; Husain AN; Hensing T; Salgia R
Adv Ther; 2011 Mar; 28(3):173-94. PubMed ID: 21337123
[TBL] [Abstract][Full Text] [Related]
2. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.
Hensing T; Chawla A; Batra R; Salgia R
Adv Exp Med Biol; 2014; 799():85-117. PubMed ID: 24292963
[TBL] [Abstract][Full Text] [Related]
3. Evolving and expanding treatment options in NSCLC.
Knoop T
Oncology (Williston Park); 2012 Aug; 26(8 Suppl Nurse Ed):13-4. PubMed ID: 25375004
[No Abstract] [Full Text] [Related]
4. Editorial: Individualizing treatment of nonsmall cell lung cancer.
Pirker R
Curr Opin Oncol; 2020 Jan; 32(1):35-36. PubMed ID: 31652144
[No Abstract] [Full Text] [Related]
5. Management of non-small cell lung cancer in the era of personalized medicine.
Rocco G; Morabito A; Leone A; Muto P; Fiore F; Budillon A
Int J Biochem Cell Biol; 2016 Sep; 78():173-179. PubMed ID: 27425397
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis.
Yu Y; He J
Front Med; 2013 Jun; 7(2):157-71. PubMed ID: 23681892
[TBL] [Abstract][Full Text] [Related]
7. Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine.
Pons-Tostivint E; Bennouna J
Curr Oncol; 2022 Sep; 29(10):7106-7108. PubMed ID: 36290835
[TBL] [Abstract][Full Text] [Related]
8. Personalizing therapy in advanced non-small cell lung cancer.
Villaruz LC; Burns TF; Ramfidis VS; Socinski MA
Semin Respir Crit Care Med; 2013 Dec; 34(6):822-36. PubMed ID: 24258572
[TBL] [Abstract][Full Text] [Related]
9. Contemporary issues in NSCLC.
Walker S
Oncology (Williston Park); 2012 Aug; 26(8 Suppl Nurse Ed):14-5. PubMed ID: 25375005
[No Abstract] [Full Text] [Related]
10. [Personalized therapy in non-small cell lung cancer: from diagnosis to therapy].
Moldvay J
Orv Hetil; 2012 Jun; 153(23):909-16. PubMed ID: 22668592
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker Interpretation.
Brown NA; Aisner DL; Oxnard GR
Am Soc Clin Oncol Educ Book; 2018 May; 38():708-715. PubMed ID: 30231309
[TBL] [Abstract][Full Text] [Related]
12. Identification of driver mutations in lung cancer: first step in personalized cancer.
Planchard D
Target Oncol; 2013 Mar; 8(1):3-14. PubMed ID: 23371030
[TBL] [Abstract][Full Text] [Related]
13. Role of artificial intelligence in the care of patients with nonsmall cell lung cancer.
Rabbani M; Kanevsky J; Kafi K; Chandelier F; Giles FJ
Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29405289
[TBL] [Abstract][Full Text] [Related]
14. The role of cytology in molecular testing and personalized medicine in lung cancer: A clinical perspective.
Young K; da Cunha Santos G; Card P; Leighl N
Cancer Cytopathol; 2019 Feb; 127(2):72-78. PubMed ID: 30512242
[No Abstract] [Full Text] [Related]
15. [Lung cancer. Molecular pathology and personalized therapy].
Schultheis A; Wolf J; Büttner R
Internist (Berl); 2013 Feb; 54(2):179-80, 182-7. PubMed ID: 23371257
[TBL] [Abstract][Full Text] [Related]
16. New Therapies and Biomarkers: Are We Ready for Personalized Treatment in Small Cell Lung Cancer?
Zhang B; Birer SR; Dvorkin M; Shruti J; Byers L
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-10. PubMed ID: 33979194
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprograming of antioxidant defense: a precision medicine perspective for radiotherapy of lung cancer?
Matschke J; Larafa S; Jendrossek V
Biochem Soc Trans; 2021 Jun; 49(3):1265-1277. PubMed ID: 34110407
[TBL] [Abstract][Full Text] [Related]
18. Toward personalized treatment approaches for non-small-cell lung cancer.
Wang M; Herbst RS; Boshoff C
Nat Med; 2021 Aug; 27(8):1345-1356. PubMed ID: 34385702
[TBL] [Abstract][Full Text] [Related]
19. Current Landscape of Personalized Therapy.
Horn L; Cass AS
Thorac Surg Clin; 2020 May; 30(2):121-125. PubMed ID: 32327170
[TBL] [Abstract][Full Text] [Related]
20. [Which platform to support a personalized lung cancer treatment?].
Ruppert AM; Antoine M; Beau-Faller M; Cadranel J; Wislez M
Bull Cancer; 2012 May; 99(5):529-34. PubMed ID: 22525302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
